Ct for Dynamic Changes in the Case of Covid-19: Therapy Using Cytokine Sorption and Selective Plasma Filtration

Zashezova, M.Kh.; Ustyuzhanin, D.; Shariya, M.A.; Певзнер, Д. В.; Ternovoy, S.K.

doi:10.21569/2222-7415-2020-10-3-20-25

Cited by 2 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The authors described a significant improvement of patient’s condition after plasma filtration. Zashezova et al [ 99 ] demonstrated a successful application of a combination of cytokine sorption using an HA330 absorber (Jafron) and selective plasma filtration using an Evaclio 2C plasma filter. The combination treatment resulted in the temperature normalization and positive dynamics of laboratory parameters, primarily CRP and IL-6.…”

Section: Selective Plasma Filtrationmentioning

confidence: 99%

Application of Extracorporeal Apheresis in Treatment of COVID-19: a Rapid Review

2022

View full text Add to dashboard Cite

Spread of a novel coronavirus infection in 2019 caused by SARS-CoV-2 virus has become a real threat to public health all around the world. The new pandemic required the mobilization of all resources for effective treatment of COVID-19 patients. Extracorporeal apheresis methods were suggested as an addition to the therapy of severe COVID-19 patients, especially when there is a threat of cytokine storm. Cytokine storm has a complex and not fully understood mechanism, and it can result in the multiple organ failure syndrome, associated with high mortality. The main cytokines that play the key role in the cytokine storm are IL-6, IL-10, and TNF-alpha. Removal of the target pro-inflammatory cytokines from the bloodstream can be beneficial in reducing the risk of complications as well as the mortality rate. We describe and compare different methods of extracorporeal apheresis: hemoadsorption, selective plasma filtration, and plasma exchange therapy in the context of their potential use in COVID-19 treatment.

show abstract

Section: Selective Plasma Filtrationmentioning

confidence: 99%

Application of Extracorporeal Apheresis in Treatment of COVID-19: a Rapid Review

2022

View full text Add to dashboard Cite

show abstract

“…На стадии разрешения заболевания уменьшается размер и количество участков уплотнения легочной ткани, исчезает симптом «булыжной мостовой», однако нередко наблюдаются субплевральные участки легочного фиброза [12]. Подобные неспецифические проявления на КТ также характерны для других вирусных пневмоний [13]. Учитывая этот факт, применение только КТ может с трудом дифференцировать и подтвердить этиологию пневмонии.…”

unclassified

Comparison of Radiology Use in the Management of Covid-19 Patients in Different Countries of the World

Серова

Pshenichnikova

Shebunina

2020

Rejr

View full text Add to dashboard Cite

андемия COVID-19 затронула практически все страны мира. Лучевые методы исследования играют ключевую роль не только в диагностике COVID-19, но и в оценке динамики течения заболевания, а также выявлении возможных осложнений. Однако тактика ведения пациентов, в том числе применения методов лучевой диагностики, значительно отличается в разных государствах. В данной статье приведены алгоритмы применения методов лучевой диагностики в тактике ведения пациентов с COVID-19 в США, России, Китае и странах Европейского региона, а также кратность и сроки проводимых исследований.

show abstract

Ct for Dynamic Changes in the Case of Covid-19: Therapy Using Cytokine Sorption and Selective Plasma Filtration

Cited by 2 publications

References 4 publications

Application of Extracorporeal Apheresis in Treatment of COVID-19: a Rapid Review

Application of Extracorporeal Apheresis in Treatment of COVID-19: a Rapid Review

Comparison of Radiology Use in the Management of Covid-19 Patients in Different Countries of the World

Contact Info

Product

Resources

About